Website profile

Biospace

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V

  • 344articles · 30d
  • 3+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 92%with images
  • 291avg words
articles per day
Categories
  • Economy, Business & Finance 196
  • Health & Wellness 161
  • Medical 159
  • Business & Industrial 143
  • Finance & Business 132
  • Health 75
  • Science & Technology 55
  • Science & Nature 36

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

BioSpace
biospace.com > press-releases > allarity-therapeutics-announces-strategic-capital-allocation-for-filing-of-spac-registration-statement

Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement

2+ day, 19+ hour ago   (373+ words) Allarity Acquisition Corp. may pursue an initial business combination in any industry, sector or geographic region. Jesper Hoiland, a current board member of Allarity and a former EVP and President of Novo Nordisk, will serve as Chairman of the board…...

BioSpace
biospace.com > press-releases > tae-life-sciences-achieves-iso-13485-certification-marking-a-major-milestone-in-quality-and-regulatory-excellence

TAE Life Sciences Achieves ISO 13485 Certification, Marking a Major Milestone in Quality and Regulatory Excellence

3+ day, 5+ hour ago   (137+ words) Audit Concluded with Zero Findings, Underscoring the Company's Commitment to Patient Safety and Medical Device Quality A Defining Milestone for TAE Life Sciences The certification was awarded following a comprehensive audit conducted by BSI (British Standards Institution), a globally recognized…...

BioSpace
biospace.com > press-releases > imds-launches-nhanceit-microcatheter-in-the-u-s-to-advance-complex-pci

IMDS Launches NHanceIT™ Microcatheter in the U.S. to Advance Complex PCI

3+ day, 5+ hour ago   (211+ words) Proprietary Skeleton Backbone™ technology introduces a new approach to catheter design to address the growing complexity in coronary interventions Powered by proprietary Skeleton Backbone technology, NHanceIT maintains force transmission from hub to distal end. True 1:1 torque response and reinforced metal…...

BioSpace
biospace.com > press-releases > three-life-saving-medical-technologies-named-finalists-for-the-second-annual-thomas-j-fogarty-innovation-prize

Three Life-Saving Medical Technologies Named Finalists for the Second Annual Thomas J. Fogarty Innovation Prize

3+ day, 5+ hour ago   (335+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...

BioSpace
biospace.com > press-releases > immuno-oncology-pioneer-dr-michael-kalos-joins-kos-biotechnology-partners-as-venture-partner

Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner

3+ day, 6+ hour ago   (313+ words) NEW YORK and ATHENS, Greece, Sept. 10, 2026 /PRNewswire/ -- Kos Biotechnology Partners, a global life sciences investment firm, today announced the appointment of renowned immuno-oncology leader Michael Kalos, PhD, as Venture Partner. Dr. Kalos brings decades of biopharmaceutical executive leadership, drug discovery,…...

BioSpace
biospace.com > press-releases > neurelis-ceo-craig-chambliss-to-present-keynote-at-the-14th-annual-outsourcing-in-clinical-trials-southern-california-2026-conference

NEURELIS CEO CRAIG CHAMBLISS TO PRESENT KEYNOTE AT THE 14TH ANNUAL OUTSOURCING IN CLINICAL TRIALS SOUTHERN CALIFORNIA 2026 CONFERENCE

3+ day, 6+ hour ago   (319+ words) SAN DIEGO, Sept. 10, 2026 /PRNewswire/ -- Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced its Founder and Chief Executive Officer Craig Chambliss will give a keynote address at the 14th Annual Outsourcing Clinical Trials (OCT) Southern California 2026 conference, to be…...

BioSpace
biospace.com > press-releases > incyte-announces-funding-of-minjuvi-tafasitamab-for-patients-with-relapsed-or-refractory-follicular-lymphoma-through-ontarios-fast-program

Incyte Announces Funding of MINJUVI® (tafasitamab) for patients with Relapsed or Refractory Follicular Lymphoma through Ontario's FAST Program

3+ day, 6+ hour ago   (346+ words) Despite advances in care, most patients with FL eventually experience relapse, highlighting the need for additional treatment options across multiple lines of therapy.3 The acceptance of cancer therapies such as MINJUVI® in the treatment of FL represents a significant step,…...

BioSpace
biospace.com > press-releases > senphonix-receives-national-science-foundation-grant-to-advance-sleevesense-a-continuous-long-term-vitals-monitoring-platform

Senphonix Receives National Science Foundation Grant to Advance SleeveSense, a Continuous, Long-Term Vitals Monitoring Platform

3+ day, 6+ hour ago   (317+ words) Federal funding backs engineering to advance the wireless and radio-frequency systems for the wearable toward manufacturing at scale, in partnership with the University of Arizona "This award is significant validation of the critical needs SleeveSense will address," said Mike Haldane,…...

BioSpace
biospace.com > press-releases > prime-therapeutics-names-manmohan-mahajan-chief-financial-officer

Prime Therapeutics names Manmohan Mahajan chief financial officer

3+ day, 6+ hour ago   (255+ words) EAGAN, Minn., Sept. 10, 2026 /PRNewswire/ -- Prime Therapeutics LLC (Prime) today announced that Manmohan Mahajan has been appointed as the company's chief financial officer (CFO), effective immediately. Mahajan brings more than 20 years of global finance and leadership experience across healthcare, pharmacy and…...

BioSpace
biospace.com > press-releases > olympus-announces-new-class-of-itind-center-of-excellence-program-physicians

Olympus Announces New Class of iTind™ Center of Excellence Program Physicians

3+ day, 6+ hour ago   (457+ words) Program Aims to Advance Minimally Invasive Treatment of Enlarged Prostate CENTER VALLEY, Pa., Sept. 10, 2026 /PRNewswire/ -- Olympus Corp. of the Americas (Olympus) is pleased to announce the newest members of the iTind™ Center of Excellence (COE) Program, which is designed to…...